Tags

Type your tag names separated by a space and hit enter

Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS.
HIV Med. 2007 Jul; 8(5):300-5.HM

Abstract

OBJECTIVE

The aim of the study was to assess the prevalence of and factors associated with use of complementary or alternative medicine (CAM) in a multistate, multisite cohort of HIV-infected patients.

METHODS

During 2003, 951 adult patients from 14 sites participated in face-to-face interviews. Patients were asked if they received treatment from any alternative therapist or practitioner in the previous 6 months. Logistic regression was performed to examine associations between demographic and clinical variables and CAM use.

RESULTS

The majority of the participants were male (68%) and African American (52%) with a median age of 45 years (range 20-85 years). Sixteen per cent used any CAM in the 6 months prior to the interview. Factors associated with use of CAM were the HIV risk factor injecting drug use [adjusted odds ratio (AOR) 0.51] compared with men who have sex with men (MSM), former drug use (AOR=2.12) compared with never having used drugs, having a college education (AOR=2.43), and visiting a mental health provider (AOR=2.76).

CONCLUSIONS

This study demonstrated similar rates of CAM use in the current highly active antiretroviral therapy (HAART) era compared with the pre-HAART era. Factors associated with CAM - such as education, use of mental health services, and MSM risk factor - suggest that CAM use may be associated with heightened awareness regarding the availability of such therapies. Given the potential detrimental interactions of certain types of CAM and HAART, all HIV-infected patients should be screened for use of CAM.

Authors+Show Affiliations

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17561876

Citation

Josephs, J S., et al. "Use of Complementary and Alternative Medicines Among a Multistate, Multisite Cohort of People Living With HIV/AIDS." HIV Medicine, vol. 8, no. 5, 2007, pp. 300-5.
Josephs JS, Fleishman JA, Gaist P, et al. Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. HIV Med. 2007;8(5):300-5.
Josephs, J. S., Fleishman, J. A., Gaist, P., & Gebo, K. A. (2007). Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. HIV Medicine, 8(5), 300-5.
Josephs JS, et al. Use of Complementary and Alternative Medicines Among a Multistate, Multisite Cohort of People Living With HIV/AIDS. HIV Med. 2007;8(5):300-5. PubMed PMID: 17561876.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. AU - Josephs,J S, AU - Fleishman,J A, AU - Gaist,P, AU - Gebo,K A, AU - ,, PY - 2007/6/15/pubmed PY - 2007/12/21/medline PY - 2007/6/15/entrez SP - 300 EP - 5 JF - HIV medicine JO - HIV Med VL - 8 IS - 5 N2 - OBJECTIVE: The aim of the study was to assess the prevalence of and factors associated with use of complementary or alternative medicine (CAM) in a multistate, multisite cohort of HIV-infected patients. METHODS: During 2003, 951 adult patients from 14 sites participated in face-to-face interviews. Patients were asked if they received treatment from any alternative therapist or practitioner in the previous 6 months. Logistic regression was performed to examine associations between demographic and clinical variables and CAM use. RESULTS: The majority of the participants were male (68%) and African American (52%) with a median age of 45 years (range 20-85 years). Sixteen per cent used any CAM in the 6 months prior to the interview. Factors associated with use of CAM were the HIV risk factor injecting drug use [adjusted odds ratio (AOR) 0.51] compared with men who have sex with men (MSM), former drug use (AOR=2.12) compared with never having used drugs, having a college education (AOR=2.43), and visiting a mental health provider (AOR=2.76). CONCLUSIONS: This study demonstrated similar rates of CAM use in the current highly active antiretroviral therapy (HAART) era compared with the pre-HAART era. Factors associated with CAM - such as education, use of mental health services, and MSM risk factor - suggest that CAM use may be associated with heightened awareness regarding the availability of such therapies. Given the potential detrimental interactions of certain types of CAM and HAART, all HIV-infected patients should be screened for use of CAM. SN - 1464-2662 UR - https://www.unboundmedicine.com/medline/citation/17561876/Use_of_complementary_and_alternative_medicines_among_a_multistate_multisite_cohort_of_people_living_with_HIV/AIDS_ L2 - https://doi.org/10.1111/j.1468-1293.2007.00474.x DB - PRIME DP - Unbound Medicine ER -